Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07648602 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

StatusRecruiting
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 2 to 1v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CorEvitas
24 trials monitored
See all monitored trials
Psoriasis
591 trials monitored
See 24 trials at risk
This is a 24-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible patients must be willing to be seen in-person by their treating physician for a Baseline visit (with first dose of the advanced therapy occurring within 14 days), and at 16 (+/- 5 days) and 24 weeks (+14 days) calculated based on date of first dose of the advanced therapy and must provide informed consent prior to enrolling in the study or completing study-specific questionnaires or procedures. Data will be collected from both subjects and their treating dermatology provider at predetermined scheduled intervals (Baseline, Week 16 and Week 24) using a structured and standardized data collection tool.
Trial Details
NCT Number NCT07648602
Lead Sponsor CorEvitas
Conditions
(from sponsor)		 Psoriasis
Related terms Psoriasis
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov